A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150 (Q80258993)
Jump to navigation
Jump to search
scientific article published on 13 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150 |
scientific article published on 13 September 2006 |
Statements
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150 (English)
A Belch
C T Kouroukis
M Crump
L Sehn
R D Gascoyne
R Klasa
J Powers
J Wright
E A Eisenhauer
13 September 2006